{
    "2018-05-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Revenue Growth",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "&quot;Fast Money&quot; final trades: SNAP, SPOT and more",
                "features": {
                    "keywords": [
                        "Fast Money",
                        "SNAP",
                        "SPOT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "tech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Top 4 Marijuana Stocks to Watch",
                "features": {
                    "keywords": [
                        "Marijuana Stocks"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "9 Winning Stocks as the Bull Loses Steam",
                "features": {
                    "keywords": [
                        "Winning Stocks",
                        "Bull Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Q1 Earnings",
                        "Sales Miss",
                        "HCV"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Analyst Recommendations for AbbVie in April",
                "features": {
                    "keywords": [
                        "Analyst Recommendations",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Health Care Conference"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "AbbVie",
                        "Better Buy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Gilead Sciences' First-Quarter Twist: Weak HIV Sales",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "First-Quarter",
                        "Weak HIV Sales"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}